C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2001
10/18/2001	WO2001077137A1 Albumin fusion proteins
10/18/2001	WO2001077136A1 Compounds and methods for lowering cholesterol levels without inducing hypertriglyceridemia
10/18/2001	WO2001077125A2 Haplotypes of the ccr5 gene
10/18/2001	WO2001076662A1 Adsorbents for dilated cardiomyopathy
10/18/2001	WO2001076642A1 Synergistic improvements to polynucleotide vaccines
10/18/2001	WO2001076641A1 Targeted death of cancer cells
10/18/2001	WO2001076639A2 Chemically-modified myelopoietin conjugates
10/18/2001	WO2001076636A2 Pharmaceutical composition of modified pna molecules
10/18/2001	WO2001076618A1 Mechanically activated channel blocker
10/18/2001	WO2001076615A2 Cxcr4 agonist treatment of hematopoietic cells
10/18/2001	WO2001076532A2 Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
10/18/2001	WO2001076529A2 Fertility associated antigen and methods of use thereof
10/18/2001	WO2001076457A2 Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
10/18/2001	WO2001076451A2 Diagnosis of diseases associated with metabolism
10/18/2001	WO2001076361A1 Animal and cell models for type ii diabetes and their use
10/18/2001	WO2001063293A8 Diagnosis and treatment of schizophrenia
10/18/2001	WO2001045737A3 Herpes simplex virus-1 glycoprotein c mutants for treating unwanted hyperproliferative cell growth
10/18/2001	WO2001040313A3 Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
10/18/2001	WO2001038357A3 Jaffa, a novel fibroblast growth factor family member and uses therefor
10/18/2001	WO2001036626A3 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds
10/18/2001	WO2001036455A3 Chlamydia antigens and corresponding dna fragments and uses thereof
10/18/2001	WO2001031015A3 36p6d5: secreted tumor antigen
10/18/2001	WO2001030966A3 An engineered recombinant molecule that regulates humoral and cellular effector functions of the immune system
10/18/2001	WO2001029210B1 A method for establishing connections between genes
10/18/2001	WO2001027613A3 Improved method for the detection of acid resistant microorganisms in a stool
10/18/2001	WO2001026608A3 Dna vaccines encoding antigen linked to a domain that binds cd40
10/18/2001	WO2001025430A3 Novel human membrane proteins
10/18/2001	WO2001023540A3 P-glycoproteins and uses thereof
10/18/2001	WO2001023415A3 Method for extracting bacterio-rhodopsin
10/18/2001	WO2001022090A9 Method for identifying compounds useful in the therapy of bone disorders
10/18/2001	WO2001021783A3 Seed-preferred promoter from maize
10/18/2001	WO2001021780A3 Targeted gene removal
10/18/2001	WO2001021199B1 Highly efficient dendritic cell-targeted dna-vaccination
10/18/2001	WO2001020336A3 SCREENING FOR α2δ-1 SUBUNIT BINDING LIGANDS
10/18/2001	WO2001020012A3 Enhanced plant cell transformation by addition of host genes involved in t-dna integration
10/18/2001	WO2001017552A8 Kaposi's sarcoma-associated herpesvirus ks-sm gene product and uses thereof
10/18/2001	WO2001016144A3 Plant derived calcium-dependent calmodulin-binding polypeptides and polynucleotides encoding same
10/18/2001	WO2001012803A3 Methods and compositions for restoring antibiotic susceptibility in glycopeptide-resistant enterococcus
10/18/2001	WO2001005971A9 Secreted polypeptides and corresponding polynucleotides
10/18/2001	WO2001004145A3 Glutx polypeptide family and nucleic acids encoding same
10/18/2001	WO2000073460A3 Modified cytokine for its stabilisation
10/18/2001	WO2000069898A8 Molecular interactions in allergy cells
10/18/2001	WO2000046236A9 Novel rgs-containing molecules and uses thereof
10/18/2001	WO2000044782A9 Ewing's tumour antigen, nucleic acid and antibodies
10/18/2001	WO2000043026A3 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation
10/18/2001	WO2000020041A9 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent
10/18/2001	US20010032344 Fertile transgenic corn plants
10/18/2001	US20010032338 Screening method for PPAR-gamma ligands
10/18/2001	US20010032337 Introduction of exogenous nucleotide sequences into a genome by microinjection of infectious retrovirus into the perivitelline space of the egg; making a bovine embryo; use to confer disease resistance, for example
10/18/2001	US20010032052 Apparatus and method for automated protein design
10/18/2001	US20010031860 Serum marker, immunohistological marker to detect prostate cancer tissues
10/18/2001	US20010031859 Human cell line characterized by expression of code sequence for antiapoptotic protein and level of cytokine production twice that of of cytokine production exhibited by parental cell line that does not express code for antiapoptotic protein
10/18/2001	US20010031856 Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs
10/18/2001	US20010031779 Methods and materials for treating and preventing inflammation of mucosal tissue
10/18/2001	US20010031725 Polysaccharides
10/18/2001	US20010031724 Dominant selectable marker for gene transformation and disruption in yeasts
10/18/2001	US20010031485 Nucleic acid coding for fusion protein which binds receptor; internalized by endocytosis; inhibits ribosomes and angiogenesis; therapy for tumors, metastasis, eye disorders, chronic inflammation and ischemic injuries
10/18/2001	US20010031484 Isolated polypeptide or fusion polypeptide; antibacterial screening
10/18/2001	US20010031476 Determining rate of bone resorption by measuring peptides in body fluid having 3-hydroxypyridinium cross-link; diagnostic tool for Paget's disease
10/18/2001	US20010031474 Chimeric neuropeptide Y receptors
10/18/2001	US20010031465 Isolated nucleic acid encoding a lamin B receptor/sterol reductase of given sequence; use to manipulate cell cycle regulation and in plant or eukaryotic cell transformability
10/18/2001	US20010031268 Neisseria culture
10/18/2001	US20010031261 Use of genetically engineered antibodies to treat multiple myeloma
10/18/2001	US20010031257 Recombinant foamy virus vectors for medicinal and diagnostic uses, and processes for preparing recombinant foamy virus vectors
10/18/2001	DE10016083A1 Nicht-menschliches Tiermodell für Wachstumsdefizienz und Defekte der Informationsverarbeitung oder der kognitiven Funktion und seine Verwendung A non-human animal model for Wachstumsdefizienz and defects of the information processing or the cognitive function and its use
10/18/2001	DE10014690A1 Expression cassette encoding non-immunogenic cell-surface receptor, useful for in vitro preparation of differentiated cells, for transplant therapy, from pleuripotent cells
10/18/2001	CA2789254A1 Signal transduction stress-related proteins and methods of use in plants
10/18/2001	CA2785943A1 Protein kinase stress-related proteins and methods of use in plants
10/18/2001	CA2767275A1 Cell cycle stress-related proteins and methods of use in plants
10/18/2001	CA2767239A1 Transcription factor stress-related proteins and methods of use in plants
10/18/2001	CA2654413A1 Use of vegf and homologues to treat neuron disorders
10/18/2001	CA2414652A1 Animal and cell models for type ii diabetes and their use
10/18/2001	CA2406485A1 Hpv-specific short-mers
10/18/2001	CA2406448A1 Identification of a human gaba transporter
10/18/2001	CA2406370A1 Gpcr-proteins and nucleic acids encoding same
10/18/2001	CA2406366A1 Muir-torre-like syndrome infhit deficient mice
10/18/2001	CA2406058A1 Tm4sf receptor polynucleotides, polypeptides, and antibodies
10/18/2001	CA2405912A1 Albumin fusion proteins
10/18/2001	CA2405870A1 Compounds and methods for lowering cholesterol levels without inducing hypertriglyceridemia
10/18/2001	CA2405800A1 Novel secreted protein
10/18/2001	CA2405750A1 Protein kinase stress-related proteins and methods of use in plants
10/18/2001	CA2405708A1 Gtp binding stress-related proteins and methods of use in plants
10/18/2001	CA2405476A1 Compounds and methods for modulating endothelial cell adhesion
10/18/2001	CA2405445A1 Fertility associated antigen and methods of use thereof
10/18/2001	CA2405424A1 Synergistic improvements to polynucleotide vaccines
10/18/2001	CA2405311A1 Multiprotein-complexes comprising a nmda receptor and uses thereof
10/18/2001	CA2405124A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof
10/18/2001	CA2405104A1 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/18/2001	CA2405083A1 New bromodomain protein
10/18/2001	CA2405029A1 Detection of erythropoietin and erythtropoietin receptor
10/18/2001	CA2404988A1 Listeria monocytogenes genome, polypeptides and uses
10/18/2001	CA2404779A1 Human lipid binding protein 1
10/18/2001	CA2404644A1 Modulators of prorenin activity
10/18/2001	CA2404229A1 Human transporters and ion channels
10/18/2001	CA2403946A1 Genes expressed in foam cell differentiation
10/18/2001	CA2403317A1 Mutant bank
10/18/2001	CA2403296A1 Proteomic analysis using activity-based probe libraries
10/18/2001	CA2403003A1 T2r taste receptors and genes encoding same
10/18/2001	CA2402410A1 The high bone mass gene of 11q13.3
10/18/2001	CA2402392A1 Non-endogenous, constitutively activated known g protein-coupled receptors

1 ... 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 ... 2916